Non-alcoholic fatty liver disease (NAFLD) is considered the major cause for the development of chronic liver alterations. Hepatic steatosis is the most benign and common form of NAFLD, although its potential to evolve into more detrimental liver alterations makes its treatment necessary. In this regard, much attention has been paid to polyphenols, with resveratrol being one of the most studied ones. This review is aimed at studying the effects induced by resveratrol on hepatic steatosis in both preclinical studies conducted under different feeding conditions (overfeeding, normal feeding and caloric restriction), and in clinical trials. The vast majority of studies have been conducted by administering the polyphenol at the same time as an ob...
This study aimed to evaluate whether resveratrol (RSV) and its microbial metabolites dihydro-resvera...
Non-alcoholic fatty liver disease (NAFLD) is a public health burden. Steatosis as the “first hit”, a...
Non-alcoholic fatty liver disease (NAFLD), which is emerging as a major public health issue worldwid...
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) are increasing clinical p...
Many studies have shown that resveratrol has a lot of therapeutic effects on liver disorders. Its ad...
The aims of the present study were to analyze the effect of resveratrol on liver steatosis in obese ...
Es reproducción del documenteo publicado en http://dx.doi.org/10.1186/1471-230X-8-40Background: The ...
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Resv...
Background & Aims: Nonalcoholic fatty liver disease (NAFLD), characterized by accumulation of hepati...
The aim of the present study was to investigate the effect of a micronized formulation of trans-resv...
Science constantly seeks to identify new molecules that could be used as dietary functional ingredie...
Steatosis is characterized primarily by excessive lipid accumulation in the form of triglycerides in...
AbstractObjectiveResveratrol (RSV) is the most studied natural compound that activates sirtuins, whi...
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD), characterized by accumulation of hepati...
This study aimed to evaluate whether resveratrol (RSV) and its microbial metabolites dihydro-resvera...
Non-alcoholic fatty liver disease (NAFLD) is a public health burden. Steatosis as the “first hit”, a...
Non-alcoholic fatty liver disease (NAFLD), which is emerging as a major public health issue worldwid...
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) are increasing clinical p...
Many studies have shown that resveratrol has a lot of therapeutic effects on liver disorders. Its ad...
The aims of the present study were to analyze the effect of resveratrol on liver steatosis in obese ...
Es reproducción del documenteo publicado en http://dx.doi.org/10.1186/1471-230X-8-40Background: The ...
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Resv...
Background & Aims: Nonalcoholic fatty liver disease (NAFLD), characterized by accumulation of hepati...
The aim of the present study was to investigate the effect of a micronized formulation of trans-resv...
Science constantly seeks to identify new molecules that could be used as dietary functional ingredie...
Steatosis is characterized primarily by excessive lipid accumulation in the form of triglycerides in...
AbstractObjectiveResveratrol (RSV) is the most studied natural compound that activates sirtuins, whi...
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD), characterized by accumulation of hepati...
This study aimed to evaluate whether resveratrol (RSV) and its microbial metabolites dihydro-resvera...
Non-alcoholic fatty liver disease (NAFLD) is a public health burden. Steatosis as the “first hit”, a...
Non-alcoholic fatty liver disease (NAFLD), which is emerging as a major public health issue worldwid...